People with depression face an increased risk of cardiovascular disease (CVD); however, more women experience CVD following a depression diagnosis than men, according to a new study published today in JACC: Asia.
Teva touts safety profile of once monthly schizophrenia therapy –
Olanzapine is an atypical antipsychotic and was first approved by the US Food and Drug Administration in 2009 by Eli Lilly. Image credit: Jonathan Weiss